
Keywords: ACEI, Angiotensin-converting enzyme inhibitor; ARB, Angiotensin II receptor blocker; CNS, Central nervous system; eGFR, Estimated glomerular filtration rate; FDA, US Food and Drug Administration; RAS, Renin angiotensin system; RRT, Renal-replacement thera